Kyoto University’s Venture Arm Launches JPY 20 Billion Fund III to Scale Deep-Tech "Patient Capital"
Kyoto University Innovation Capital (Kyoto iCAP) has established its third flagship investment vehicle, the Innovation Kyoto 2026 Investment Limited Partnership (KYOTO-iCAP Fund III).
Managed by Kyoto iCAP as the general partner under the leadership of Representative Director Ko Kusumi, the new fund scales the university’s commitment to commercializing high-level academic research. With a target committed capital of JPY 20 billion, the fund follows the successful deployment of Fund I (2016) and Fund II (2021).
A Strategy of "Patient Capital"
Fund III features a fund life of 15 years, with the potential for a two-year extension, thus distinguishing it from traditional venture capital. This extended horizon is specifically designed to provide "patient capital"—the long-term, sustained support required for startups originating from Kyoto University and other Japanese national universities to navigate the lengthy development cycles inherent in deep-tech and life sciences.
Blue-Chip Institutional Support
The fund has already attracted a high-profile roster of limited partners (LPs) from the financial and industrial sectors. Key participants include:
- Pharmaceuticals: Astellas Pharma
- Banking: Bank of Kyoto, The Senshu Ikeda Bank, and Sumitomo Mitsui Trust Bank
- Industry & Infrastructure: Shimadzu Corporation, Tokyu Land Corporation, and Cosmo Energy Holdings
- Insurance: Nippon Life Insurance Company
Fueling the Startup Pipeline
Fund III aims to intervene at the early stages of development, providing the necessary runway for university-born startups to reach maturity. By de-risking these ventures, Kyoto iCAP intends to attract further private sector investment, accelerating the transition of laboratory breakthroughs into viable commercial businesses.
The establishment of this third fund reinforces Kyoto iCAP’s role as a primary engine for Japan’s innovation ecosystem, bridging the gap between national research excellence and global market competitiveness.
Norbert Gehrke
